全球微型RNA市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年， 微型RNA市場規模將從 2025 年的 28 億美元成長至 292.3 億美元，2026 年至 2034 年的複合年成長率為 29.76%。

隨著分子生物學和基因診斷研究的不斷深入，全球微型RNA市場正蓬勃發展。 microRNA在基因調控和疾病進展中發揮著至關重要的作用，並作為癌症和其他慢性疾病的重要生物標記而備受關注。基因組研究投入的增加正顯著推動市場成長。

關鍵成長要素包括RNA定序技術的進步和個人化醫療方法的日益普及。製藥公司正在探索基於微型RNA的療法，並加強其研發管線。政府資助和與學術機構的合作也促進了市場成長。

展望未來，RNA遞送系統和診斷平台的技術進步可望進一步拓展其臨床應用。將微型RNA研究融入精準醫療策略，可望開闢新的治療途徑，並支持市場的長期發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球微型RNA市場：依服務分類

• 市場分析、洞察與預測
• 檢體
• 服務類型

第5章 全球微型RNA市場：依產品分類

• 市場分析、洞察與預測
• 裝置
• 消耗品

第6章 全球微型RNA市場：依應用分類

• 市場分析、洞察與預測
• 癌症
• 感染疾病
• 免疫疾病
• 心血管疾病
• 神經系統疾病
• 其他

第7章：全球微型RNA市場：依最終用途分類

• 市場分析、洞察與預測
• 生物技術和製藥公司
• 學術機構與政府研究機構
• 其他

第8章 全球微型RNA市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Horizon Discovery Ltd
  • Synlogic
  • Qiagen
  • GeneCopoeia Inc
  • New England Biolabs
  • Quantabio
  • NanoString
  • BioGenex
  • SeqMatic LLC
  • Miltenyi Biotec
  • Sistemic Scotland Limited
  • Biodynamics Laboratory Inc
  • OriGene Tec

The MicroRNA Market size is expected to reach USD 29.23 Billion in 2034 from USD 2.80 Billion (2025) growing at a CAGR of 29.76% during 2026-2034.

The global microRNA market is gaining momentum due to growing research in molecular biology and genetic diagnostics. MicroRNAs play a crucial role in gene regulation and disease progression, making them valuable biomarkers for cancer and other chronic conditions. Rising investments in genomics research are significantly supporting market expansion.

Key growth drivers include advancements in RNA sequencing technologies and increasing adoption of personalized medicine approaches. Pharmaceutical companies are exploring microRNA-based therapeutics, strengthening the research pipeline. Government funding and academic collaborations further contribute to market growth.

Looking ahead, technological improvements in RNA delivery systems and diagnostic platforms are expected to enhance clinical applications. The integration of microRNA research into precision medicine strategies may open new treatment opportunities, supporting long-term market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Services

• Specimen
• Service Type

By Products

• Instruments
• Consumables

By Application

• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

By End-Use

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

COMPANIES PROFILED

• Merck KGaA, Thermo Fisher Scientific Inc, Horizon Discovery Ltd, Synlogic, Qiagen, GeneCopoeia Inc, New England Biolabs, Quantabio, NanoString, BioGenex, SeqMatic LLC, Miltenyi Biotec, Sistemic Scotland Limited, Biodynamics Laboratory Inc, OriGene Tec
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MICRORNA MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Specimen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Service Type Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MICRORNA MARKET: BY PRODUCTS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Products
• 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MICRORNA MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Immunological Disorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Neurological Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MICRORNA MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Government Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MICRORNA MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Services
  • 8.2.2 By Products
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Services
  • 8.3.2 By Products
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Services
  • 8.4.2 By Products
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Services
  • 8.5.2 By Products
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Services
  • 8.6.2 By Products
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MICRORNA INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Merck KGaA
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 Horizon Discovery Ltd
  • 10.2.4 Synlogic
  • 10.2.5 Qiagen
  • 10.2.6 GeneCopoeia Inc
  • 10.2.7 New England Biolabs
  • 10.2.8 Quantabio
  • 10.2.9 NanoString
  • 10.2.10 BioGenex
  • 10.2.11 SeqMatic LLC
  • 10.2.12 Miltenyi Biotec
  • 10.2.13 Sistemic Scotland Limited
  • 10.2.14 Biodynamics Laboratory Inc
  • 10.2.15 OriGene Tec